Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-56.61	-50.61	-27.31	-12	-7.18
Depreciation & Amortization	0.63	0.44	0	0	0
Share-Based Compensation	12.58	11.41	4.36	1.05	0.32
Other Operating Activities	-6.23	5.81	-4.25	6.09	2.06
Operating Cash Flow	-49.63	-32.95	-27.19	-4.85	-4.81
Capital Expenditures	-0.07	-0.46	0	0	0
Change in Investments	-68.69	-116.84	0	0	0
Investing Cash Flow	-68.76	-117.29	0	0	0
Share Issuance / Repurchase	49.74	0.18	163.89	0	0
Other Financing Activities	-	-	99.89	11.99	2.99
Financing Cash Flow	49.74	0.18	263.78	11.99	2.99
Net Cash Flow	-68.65	-150.06	236.58	7.14	-1.81
Free Cash Flow	-49.7	-33.4	-27.19	-4.85	-4.81
Free Cash Flow Per Share	-1.14	-0.87	-2.82	-8.54	-30.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).